Argitalpenak (79) MARÍA ELENA CELA DE JULIÁN argitalpenak

2024

  1. Madrid Newborn Sickle Cell Disease Cohort: clinical outcomes, stroke prevention and survival

    Annals of Hematology, Vol. 103, Núm. 2, pp. 373-383

  2. Spanish registry of hemoglobinopathies and rare anemias (REHem-AR): demographics, complications, and management of patients with β-thalassemia

    Annals of Hematology

2023

  1. Challenges and Opportunities of Precision Medicine in Sickle Cell Disease: Novel European Approach by GenoMed4All Consortium and ERN-EuroBloodNet

    HemaSphere

  2. Development of a centralised triage centre for children with cancer and blood disorders in response to the humanitarian crisis in Ukraine

    The Lancet Oncology

  3. Invasive Bacterial Infections in Children With Sickle Cell Disease: 2014–2019

    Pediatrics, Vol. 152, Núm. 4

  4. Sickle cell disease landscape and challenges in the EU: the ERN-EuroBloodNet perspective

    The Lancet. Haematology, Vol. 10, Núm. 8, pp. e687-e694

2022

  1. Risk-score based strategy to minimize antibiotic exposure in children with sickle cell disease and fever

    Infection, Vol. 50, Núm. 2, pp. 499-505

  2. Sickle cell disease in pediatric intensive care

    Anales de pediatria, Vol. 97, Núm. 1, pp. 61-62

  3. Sickle cell disease: Challenging the past, looking to the future

    Anales de Pediatria, Vol. 97, Núm. 1, pp. 1-3

2021

  1. Complete RH and Kell matching related to low alloimmunisation risk in sickle cell disease: prevalence and risk factors of alloimmunisation in a Spanish Tertiary Care National Reference Centre

    Blood transfusion = Trasfusione del sangue, Vol. 19, Núm. 4, pp. 292-299

  2. Complications of Central Venous Access Devices in Patients with Sickle Cell Disease and Thalassemia Major

    Journal of Pediatric Hematology/Oncology, Vol. 43, Núm. 5, pp. E655-E660

  3. Interleukin 6 as a marker of severe bacterial infection in children with sickle cell disease and fever: a case–control study

    BMC Infectious Diseases, Vol. 21, Núm. 1

  4. Matched sibling donor stem cell transplantation for sickle cell disease: Results from the Spanish group for bone marrow transplantation in children

    European Journal of Haematology, Vol. 106, Núm. 3, pp. 408-416

  5. Pharmacokinetics and safety of ticagrelor in infants and toddlers with sickle cell disease aged <24 months

    Pediatric Blood and Cancer, Vol. 68, Núm. 5

2020

  1. COVID-19 infection in children and adolescents with cancer in Madrid

    Pediatric Blood and Cancer

  2. Detection of Respiratory Viruses in the Clinical Outcome of Children With Fever and Neutropenia

    Pediatric Infectious Disease Journal, Vol. 39, Núm. 6, pp. 533-538

  3. Evaluation of the effectiveness of prophylactic oral vitamin D (cholecalciferol) in children with sickle cell disease

    Bone, Vol. 133

  4. Fifteen years of newborn sickle cell disease screening in Madrid, Spain: an emerging disease in a European country

    Annals of Hematology, Vol. 99, Núm. 7, pp. 1465-1474

  5. Optimised molecular genetic diagnostics of Fanconi anaemia by whole exome sequencing and functional studies

    Journal of Medical Genetics, Vol. 57, Núm. 4, pp. 258-268

  6. Update of the Spanish registry of haemoglobinopathies in children and adults

    Medicina Clinica, Vol. 155, Núm. 3, pp. 95-103